twoXAR functions as a company specializing in pharmaceutical discovery driven by artificial intelligence. Its computational platform is utilized to pinpoint potential drug prospects, mitigate risks through preliminary studies, and advance candidates to clinical trials via partnerships with industry and investors. The synergy of massive data, cloud computing, and artificial intelligence has empowered twoXAR to construct a drug discovery platform that surpasses traditional methods in terms of speed, cost-effectiveness, and precision. twoXAR employs its technology internally to establish a therapeutic pipeline encompassing various ailments.